EMA Recommendations on Compassionate Use of Remdesivir for COVID-19


Applied Clinical Trials

During a virtual meeting held on April 2nd, EMA’s human medicines committee gave recommendations on how the investigational antiviral medicine remdesivir should be used for treating coronavirus disease in compassionate use programs. 

To read the reccomendations, click here.

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.